Harnessing Biopolymer Gels for Theranostic Applications: Imaging Agent Integration and Real-Time Monitoring of Drug Delivery

Biopolymer gels have gained tremendous potential for therapeutic applications due to their biocompatibility, biodegradability, and ability to adsorb and bind biological fluids, making them attractive for drug delivery and therapy. The versatility of biopolymer gels in theranostic backgrounds, with a focus on integrating imaging features and facilitating real-time monitoring of drug delivery. Different methods of delivery are explored imaging agents into biopolymer gels, including encapsulation, surface functionalization, nanoparticle encapsulation and layer-by-layer assembly techniques. Integration of Agents and Real-Time Monitoring Drug Delivery We summarize the synthesis methods, general properties, and mechanisms of biopolymer gels functionality, demonstrating their broad applications as multimodal systems for imaging-based therapeutics. These techniques not only enable multiple imaging but also provide signal enhancement and imaging a targeted facilitates, increasing the diagnostic accuracy and therapeutic efficacy. In addition, current techniques for incorporating imaging agents into biopolymer gels are discussed, and their role in precise drug delivery and monitoring.

Keywords:

Subject: Medicine and Pharmacology - Pharmacy

1. Introduction

Biopolymer gels have gained significant attention in recent years for their potential use in drug delivery platforms and theranostic applications. Biocompatibility and biodegradability are fundamental necessities for biomedical applications, and biopolymeric hydrogels are especially valuable in the organization of medications and theranostics because of their capacity to retain and hold a significant measure of water and natural media [1].Theranostic viability can be expanded by reorganization drug loading and controlling delivery attributes under specific biological feeling conditions as per the exceptional permeable organization construction of hydrogels in light of biopolymers [1]. Since biopolymers arrive in an extensive variety of miniature/nanogel structures that are great for the vast majority harmless to the ecosystem applications, they are believed to be a decent choice for tending to biocompatibility and biodegradability challenge [2]. The capability of biopolymer-based miniature/nanogels as medication transporters in biomedical applications has been researched; studies have featured the utilization of a few biopolymers in the plan of nanogels and flow improvements in drug and biomolecule conveyance applications. The utilization of miniature/nanogels as medication transporters and the development using regular gums and their derivatives are of immense importance [3] .

Biopolymer-based nanogels have additionally been researched for their capability to ship meds and biomolecules because of their high retention limit of water and natural liquids [4]. The surveys examined the utilization of different biopolymer-based miniatures or nanogels for drug conveyance in biomedical applications as listed in Figure 1. They underline the headway made in epitomizing atoms with different restorative purposes utilizing biopolymer-based nano/microgels, as well as clever ways to deal with amalgamation or potentially functionalization to upgrade their conveyance capacities. In current medication, the rising significance of the union among diagnostics and treatments has prompted the development of the theranostic worldview [5]. This coordinated methodology is focused on effectively connecting indicative capacities with restorative activities, empowering the arrangement of individualized and exact treatments for different problems. Huge commitment is held by theranostic procedures for working on understanding results while limiting secondary effects, as they give continuous information on treatment adequacy and illness movement [6].

As the field of medication goes through a worldview change, theranostics rises above conventional limits among determination and treatment. Utilizing a synergistic methodology that consolidates restorative methodologies coordinated by demonstrative strategies, it gives exact and tweaked patient consideration. Through early ailment ID and constant observing of treatment reaction, doctors might fit treatment techniques to every patient's Biopolymer gels certainly stand out lately for their possible use in drug conveyance stages and theranostic applications [7]. Biocompatibility and biodegradability are necessities for biomedical applications, and biopolymeric hydrogels are especially helpful in the organization of medications and theranostics because of their capacity to assimilate and hold a significant measure of water and natural media [8]. Theranostic viability can be expanded by advancing medication stacking and controlling delivery qualities under specific organic excitement conditions as indicated by the exceptional permeable organization design of hydrogels in view of biopolymers [9]. Since biopolymers arrive in an extensive variety of miniature/nanogel structures that are great for the majority harmless to the ecosystem applications, they are believed to be a decent choice for tending to biocompatibility and biodegradability challenges [10]. The capability of biopolymer-based miniature/nanogels as medication transporters in biomedical applications has been examined; studies have featured the utilization of a few biopolymers in the plan of nanogels and their ongoing improvements in drug and biomolecule conveyance applications [11]. The utilization of miniature/nanogels as medication transporters and the creation processes using regular gums and their subordinates are additionally remembered for the surveys [12].

Biopolymer-based nanogels have additionally been explored for their capability to move drugs and biomolecules because of their high ingestion limit of water and natural liquids [13]. The audits that are examine the utilization of different biopolymer-based miniatures and nanogels for drug conveyance in biomedical applications. They underline the headway made in epitomizing particles with different restorative purposes utilizing biopolymer-based nano/microgels, as well as clever ways to deal with combination or potentially functionalization to improve their conveyance abilities [14]. In present day medication, the rising significance of the assembly among diagnostics and treatments has prompted the development of the theranostic worldview [15]. This coordinated methodology is focused on effectively connecting demonstrative abilities with restorative activities, empowering the arrangement of individualized and exact treatments for different problems. Tremendous commitment is held by theranostic strategies for working on quiet results while limiting aftereffects, as they give constant information on treatment viability and sickness movement [16].

Finally, theranostic as a worldview change in the field of medication transcends the conventional limits among determination and treatment. It’s anything but a synergistic methodology combining the remedial methodologies coordinated by demonstrative strategies for giving exact and customized patient consideration. Theranostic provides early sickness distinguishing proof and tries to monitor treatment reaction so many treatment methodologies could be adjusted to patients’ particular necessities. Besides, theranostic approaches may improve helpful outcomes by limiting adverse consequences and improving medication circulation. As a result of their excellent features, including biocompatibility, mechanical qualities that may be readily functionalized, and ease of use, theranostic applications have discovered excellent flexibility in biopolymer gels [17]. These gels, which are created with highly regular, synthetic polymers, can be utilized to create a three-layered network structure capable of holding medical substances and imaging probes. The important point is that drug delivery might be prompted by certain physiological signs or external factors through the fabrication of a bio-polymer gel that exhibits a responsive stimulus [18]. As well, compared to traditional drug delivery systems, their organic biodegradability can significantly reduce the problems of toxicity and accumulating for a long time [19].

Biopolymer gels such as alginate, gelatin, and chitosan are used to create scaffolds that support cell growth and tissue formation [20]. Their biocompatibility and biodegradability are crucial for successful tissue regeneration. 3D printed biopolymer gels can be designed to deliver drugs precisely at the site of interest. For example, hydrogels made from alginate or gelatin can be loaded with chemotherapy drugs and printed into shapes that fit the tumor site exactly. Biopolymer gels can encapsulate living cells, allowing for the creation of complex tissue structures [21]. Hydrogels like collagen and hyaluronic acid provide a supportive environment for cell proliferation and differentiation. Biopolymer gels can be combined with other materials, such as nanoparticles or fibers, to enhance their properties for specific applications. Biopolymer gels-based implants not only deliver drugs but also monitor therapeutic outcomes. For example, a 3D printed implant release anti-inflammatory drugs while simultaneously measuring local inflammation levels [22].

Theranostic approaches can also help to improve the outcomes of restorative therapy through diminishing unwanted effects and improving drug delivery. These methods have displayed an exceptional flexibility in biopolymer gels due to their peculiarities such as biocompatibility, easily modifiable mechanical characteristics and user friendliness. These natural or artificial polymer gels can be organized into three-layer network structure capable of retaining therapeutic substances and imaging agents. However, it is important to note that bio-polymeric gels are stimuli-responsive and so can deliver drugs upon particular physiological signals or external stimuli [23].

2. Intersecting Diagnosis with Therapy

The word “theranostic”, which combines the words “therapy” and “diagnostics” signifies a concept that emphasizes on integrating diagnostic capabilities with therapeutic treatments. In most cases, traditional means of diagnosis are used prior to making treatment choices hence there is a systematic approach to patient care with a degree of fragmentation involved. Conversely, theranostic fills this void by delivering therapeutic agents alongside providing timely assessment of treatment efficiency [24]. This integration provides broad knowledge about the progression of illnesses and outcome of treatments, thus making it easy for a clinician to interact with patients. This is because theranostic platforms are able to detect an infection at early stages, follow the progress made in treatment and adjust treatment schedules. The use of diagnostic techniques such as imaging or biomarker analysis enables health care practitioners to understand the nature of a disease in terms of its features, molecular markers, spatial distribution of pathologic lesions. These details thereby assist in selecting and planning treatment procedures that are rational, timely, specific and individualized per patient’s requirements. Furthermore, due to continuous interaction between therapies and diagnostics there is flexibility when choosing various approaches to therapy that lead to decreased side effects and development of resistance therapies [25].

3. Biopolymer Gels as Versatile Platforms

Biopolymer gels have been described as biocompatible, tunable and can be functionalized easily making them ideal for a variety of biomedical applications. The positive features of these materials are due to the fact that they create a three-dimensional structure having high water content which is similar to the living tissues extracellular matrix environment through natural and synthetic polymers. As such, they exhibit improved cellular interactions, adjustable mechanical properties, sustained drug release kinetics and other advantageous traits that resemble those of naturally occurring biological systems [26].

The responsive gelation process is one reason among many others why biopolymer gels are highly versatile. When exposed to environmental conditions like changes in pH, temperature variations, light etc., the gelling state may change reversibly [27]. In effecting-controlled release drug delivery this system has precise control over drug release kinetics [28].

Furthermore, biopolymer gels can be designed specifically for certain types of cells or molecules; Reducing off-target effects therefore enables targeted treatment. Biopolymer gels are used because of their porous nature that allows the incorporation of imaging agents. This means images can be captured and treatment response monitored in real time. Biopolymer-based theranostic platforms can be considered as heterogeneous with no restrictions between diagnosis and treatment due to the direct incorporation of imaging agents into the gel structure, thus opening the door to individualized therapeutic approaches [26].

To accomplish localized cancer therapy and tumor imaging, injectable hydrogels preloaded with chemotherapeutic medications and imaging contrast agents can be utilized. Polyethylene glycol (PEG) and chitosan can be coupled with the contrast agent gadolinium and the chemotherapeutic drug doxorubicin. The hydrogel can target the tumor site precisely after injection, making it possible to continuously release medication and make tumor MRI imaging easier. Growth hormones, such as epidermal growth factor (EGF), and pH sensors can be included into hydrogels composed of gelatin and hyaluronic acid. When applied to wounds, this hydrogel can hasten the healing process and provide instantaneous information about the surrounding environment, assisting in the proper course of therapy [29].

nanogels that have been fitted with MRI contrast agents and altered to target cancer cells with ligands. Folic acid conjugation with poly(lactic-co-glycolic acid) (PLGA) and PNIPAM nanogels allows for the selective targeting of cancer cells expressing overexpressed folate receptors [30]. The nanogels have the capacity to transfer superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic resonance imaging, together with the chemotherapeutic drug paclitaxel. This makes it possible to view cancers and treat them specifically. It is possible to incorporate a fluorescent marker and plasmid DNA containing a therapeutic gene into chitosan-based nanogels. The gene is triggered in the target cells upon delivery, and the fluorescent marker aids in monitoring the location and efficacy of gene expression [31].

The PEG and alginate cryogel can incorporate glucose oxidase and doxorubicin sensors. This scaffold can be placed in the location where a tumor was excised in order to track blood sugar levels and administer medication there. This makes it possible to evaluate the tumor's response to therapy as well as its metabolism [32]. Collagen and hyaluronic acid cryogels have the ability to integrate growth agents and oxygen sensors. Cryogels have the capacity to replenish bone or cartilage and provide instantaneous oxygen level readings. For tissues to operate and survive as best they can, this knowledge is essential [33].

4. Properties and Characteristics of Biopolymer Gels.

Biopolymer gels are multifunctional materials with unique properties that make them ideal for various biomedical applications such as drug delivery, tissue engineering, theranostic, etc. These gels contain natural or synthetic polymers that can form crosslinked networks for so it offers a variety of options [34]. Natural polymers such as alginate, chitosan, collagen, hyaluronic acid, and gelatin have inherent biocompatibility while their man-made counterparts such as polyethylene glycol (PEG), polyvinyl alcohol (PVA) and poly(N-isopropylacrylamide) also offers adjustable for features such as improved mechanical strength [35]. Some important properties affecting the three-dimensional interface structure of biopolymer gels are mechanical properties, pore size distribution, drug release kinetics. Manipulation of parameters such as crosslinking density and polymer concentration can be a variety of factors. These gels respond to external stimuli such as temperature pH, or light and therefore can be reversibly modified [36]. The interaction between negatively charged alginate and positively charged chitosan results in the formation of a stable gel with favorable mechanical properties. The gel has the capacity to incorporate and retain a significant amount of water due to the hydrophilic nature of both PVA and PAA. The gel's characteristics can be modified by modifying the ionic content, which is advantageous for sensor applications [37]. The mechanical characteristics of gelatin-polyethylene glycol can be altered by adjusting the gelatin to polyethylene glycol ratios. The thermosensitive properties of these polymers enable them to solidify at body temperature. It is possible to engineer gels composed of hyaluronic acid and poly(lactic-co-glycolic acid) (PLGA) to discharge medications or other bioactive substances under controlled conditions [38]. PLGA imparts mechanical strength to the hyaluronic acid gel, which is otherwise pliable. The mechanical resilience of agarose-poly(N-isopropylacrylamide) (PNIPAAm) gels enables reversible sol-gel transitions. The lower critical solution temperature (LCST) of the well-known thermoresponsive polymer poly(N-isopropylacrylamide) (PNIPAM) is approximately 32°C. The flexibility of PNIPAM-based gels and polymers is advantageous for wearable and conformable applications. The PNIPAM-Chitosan gel exhibits dual stimuli responsiveness by reacting to changes in temperature and Ph [39]. These characteristics make them suitable for targeting as their mechanism of action enhances their drug delivery to be useful in a variety of applications Biodegradability and biocompatibility are important considerations when organisms in biopolymers mimic aspects of the extracellular matrix that support cell adhesion and tissue regeneration [40]. Controlled cell degradation is important for gel breakdown into non-toxic products, which is key to maintaining long-term drug release and reducing side effects as listed in Figure 2. Furthermore, the scalable mechanism of biopolymer gels is important because it can mimic native tissue and withstand physiological stress. This flexibility makes them useful for a variety of biomedical applications, including clinical and diagnostics [41].

5. Imaging Agents in Theranostic Applications

Imaging modalities play an important role in treatment by providing valuable information on disease location, progression, and treatment response. An overview of the imaging techniques is provided, the clinical importance of imaging materials is discussed, and the various imaging materials commonly used in biomedical research and clinical practice [42].

Imaging techniques covered several techniques based on physical principles, such as X-ray, ultrasound, magnetic resonance, fluorescence, and nuclear imaging and these techniques produce detailed images with spatial and temporal resolution high-quality. Each modality has specific advantages and limitations, making it suitable for different applications in theranostic [43].

X-ray imaging such as radiography and computed tomography (CT) rely on the contrast of X-rays absorbed by tissues to create detailed images of the body This technique is commonly used to detect bone fractures, diagnose and monitor tumors how doctors intervene [44].

Ultrasound imaging uses high-frequency sound waves to create real-time images of organs and tissues in the body. This noninvasive, portable, and radiation-free technique is suitable for a variety of diagnostic and interventional procedures [45].

MRI technology relies on magnetic fields and radio waves to generate contrast images of soft tissue, ideally suited to imaging the brain, spinal cord and musculoskeletal systems, as well as detect tumors and inflammation [46].

Fluorescence imaging uses fluorescent dyes or materials that emit light upon excitation by an external source, enabling the detection of specific molecular targets, biomarkers, or cellular processes with high sensitivity and specificity [47].

Nuclear imaging modalities, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) use radioactivity for detailed functional imaging to provide quantitative information on tracer uptake, metabolism, and biological distribution important for molecular analysis and anatomical imaging [48].

Among the therapies, the selection of appropriate imaging agents is important for accurate diagnosis, treatment planning, and monitoring of therapeutic response When different imaging modalities and agents are used, individual exposure intervention can benefit from improved outcomes [49].

Table 1. Imaging agent and their applications.

Imaging Modality	Imaging Agent	Theranostic Application
X-ray Imaging	Iodine-based contrast agents	Diagnosis of bone fractures, detection of tumors, and monitoring therapeutic interventions	[50]
X-ray Imaging	Barium sulfate	Visualization of gastrointestinal tract for diagnosing conditions like ulcers or tumors	[50]
Ultrasound Imaging	Microbubble contrast agents	Assessing blood flow, visualizing organs, and guiding interventional procedures	[51]
Ultrasound Imaging	Contrast-enhanced ultrasound	Imaging liver lesions, assessing vascularity in tumors, and diagnosing cardiovascular conditions	[51]
Magnetic Resonance Imaging	Gadolinium-based contrast agents	Imaging brain, spinal cord, and musculoskeletal system, detecting tumors, and inflammatory processes	[52]
Magnetic Resonance Imaging	Superparamagnetic iron oxide nanoparticles	Targeted drug delivery and imaging of inflammation	[52]
Fluorescence Imaging	Fluorescent dyes	Visualizing specific molecular targets, biomarkers, or cellular processes with high sensitivity	[53]
Fluorescence Imaging	Quantum dots	Multiplexed imaging of molecular targets for personalized medicine	[53]
Nuclear Imaging	Fluorodeoxyglucose	Cancer diagnosis and monitoring response to treatment	[54]
	Technetium-99m labeled agents	Imaging myocardial perfusion and diagnosing bone metastases
	Copper-64 labeled nanoparticles	Imaging and tracking of stem cell therapy

6. Importance of Imaging Agents in Theranostic

In theranostic, dual roles are served by imaging agents as diagnostic tools and therapeutic agents, enabling the integration of diagnostics and therapeutics into a unified platform. Through the incorporation of imaging agents directly into therapeutic formulations or delivery vehicles, disease progression can be monitored, treatment response assessed, and therapeutic regimens optimized in real time by clinicians [55]. Non-invasive visualization of drug distribution, pharmacokinetics, and pharmacodynamics is facilitated by imaging agents, allowing for personalized treatment strategies tailored to individual patient profiles. Moreover, early detection of treatment resistance, identification of therapeutic targets, and prediction of treatment outcomes are enabled by imaging agents, thereby improving patient outcomes and reducing healthcare costs [56].

Numerous imaging agent are available for use in theranostic applications, such as contrast agents, fluorescent dyes and probes, radiotracers, nanoparticles, and molecular probes, each possessing unique properties and applications as listed in Figure 3.

Contrast agents enhance the visibility of anatomical structures or pathological lesions on imaging scans by altering the contrast between tissues. Examples include iodinated contrast agents for X-ray and CT imaging, gadolinium-based contrast agents for MRI, and microbubbles for ultrasound imaging. Fluorescent dyes and probes emit light at specific wavelengths upon excitation by external sources, enabling visualization of molecular targets, cellular processes, and biological interactions [57]. They are commonly used in preclinical research and intraoperative imaging for guiding surgical resection of tumors. Nanoparticles that contain imaging agents such as quantum dots, iron oxide nanoparticles and gold nanoparticles make possible multi-modal imaging and focused drug delivery. They are important as they have more stability, a long time in circulation and can be targeted towards specific sites. Molecular probes have been developed to target disease-specific biomarkers or molecular pathways, thus allowing selective imaging of different diseases. Consequently, they can be tagged with fluorescent dyes, radioactive tracers or MRI contrast agents for substantial results through several imaging methods [58].

7. Integration of Imaging Agents with Biopolymer Gels

Combining biopolymer gels with diagnostic tools improves diagnosis, therapy and monitoring. Signal strength is improved through strategies which enhance biocompatibility with respect to biomedical applications in safety terms [59].

Different methods have been developed for incorporating imaging agents inside biopolymer gels, allowing multimodal imaging and monitoring therapeutic interventions in real time [60].

Encapsulation: During gelation, the imaging agents can be enclosed inside the gel matrix via physical entrapment or chemical conjugation. For example, prior to the gel formation, fluorescent dyes, contrast agents or radiotracers can be mixed with polymer solution to ensure that they are uniformly distributed within the gel matrix [61].

Surface functionalization of biopolymer gels can be modified by targeting ligands or affinity moieties to specifically bind a range of imaging agents to enhance their retention and localization in the gel Supervised [62].

The versatility and potential of biopolymer-based imaging agents for theranostic applications, including their ability to be tailored for specific biomedical applications has been illustrated in Table 2. Their biocompatibility and biodegradability, and their potential for real-time monitoring of treatment responses are witnessed by these examples.

8. Role of Biopolymer Gels in Real-Time Monitoring

A few strategies can be employed in combination with biopolymer gels to improve imaging signals and increase the sensitivity and specificity of imaging modalities:

Combining biopolymer gels with imaging techniques offers a promising approach to improve sensitivity and specificity in medical imaging. Signal enhancement techniques, such as conjugation of signal amplification probes and imaging agents of nanoparticles or enzymes, enable the detection of low-level imaging materials with high sensitivity and resolution Furthermore, many images using biopolymer gels with imaging techniques are used to obtain and provide coverage information, compensate for individual errors, and even provide accurate analysis, selective imaging obtained by targeting biopolymer gels with ligands or antibodies [71]. A operationalization facilitates accurate localization of infectious lesions and early diagnosis, thereby guiding treatment decisions for better patient outcomes [72].

In theranostic platforms, biocompatibility considerations are most important. In vitro cytotoxicity assessment provides important information about the compatibility of imaging agents and biopolymer gels with cells. The optimization of medication loaded in the biopolymer gels to ensure a safe in vivo experience by surface modification methods and, degradation of biopolymer gels by phototherapy treatment representative for a period of time is crucial. Beneficial substances are released sequentially, where the deleterious substances are non-toxic, and are easily metabolized or eliminated from the body. Compliance with regulatory requirements including clinical safety assessment is essential for developing treatment to ensure individual safety and efficiency [73].

Biopolymer gels have several compelling features to be employed in real-time tracking of drug administration. First, the crucial advantage is their tunability and stimuli-responsive behavior, which allows their controlled dissolution and disintegration upon external action. They can also readily encapsulate imaging agents within their matrix, which permits monitoring of the release kinetics or in situ distribution within the target area. The use of biopolymer gels provides for on-demand changes in the drug release rate based on physiological conditions or external agents, which also significantly increases treatment selectivity. Moreover, biopolymer gels simultaneously act as reservoirs for sustained release of the drug and carriers for its delivery. Biopolymer gels can further be engineered to possess specific properties, such as injectability, shear-thinning behavior, or mucoadhesive properties to allow for facile minimally invasive administration and localized drug delivery to disease tissue. This promotes optimal patient comfort and compliance while reducing the necessity for frequent dosing, making them particularly well-suited for chronic or localized conditions. [5,74].

Biopolymer gels offer great potential for applications in various fields such as tissue engineering, regenerative medicine, and drug delivery, particularly in real-time monitoring methods [75]. Drug delivery systems based on biopolymers enable precise delivery of therapeutic agents to tumor tissues in targeted cancer therapy. By utilizing advanced scientific methods, the potential for harmful effects on the body is minimized. Additionally, this approach enables the development of personalized treatment strategies that rely on continuous evaluation of drug administration and how the tumor reacts. In addition, biopolymer gels are ideal for long-term intervention therapy in chronic conditions such as diabetes and heart disease due to their ability to provide regulated medication release. In applications of regenerative medicine, they also contribute to the promotion of wound healing and tissue regeneration [76]. Monitoring drug release kinetics and tissue remodeling processes in real-time can significantly improve the effectiveness of therapies and allow for personalized treatment plans that cater to the unique needs of each patient.

Recent advancements in biopolymer gel formulations, imaging methods, and monitoring technologies have greatly expedited the progress of next-generation theranostic systems for personalized medicine and healthcare. New gel systems like hydrogels, nanogels, and cryogels offer versatile platforms for imaging, drug delivery control, and real-time analysis. [77]. By leveraging the unique properties of these gel systems, researchers can develop innovative pharmaceutical strategies that combine drug delivery, imaging, and real-time monitoring, paving the way for personalized medicine, regenerative medicine, and precision healthcare approaches that optimize therapeutic outcomes for patients [78].

9. Challenges in Conventional Drug Delivery Monitoring

Monitoring drug delivery through traditional techniques is primarily based on indirect measurements with reasonable limitations to quantifying fundamental aspects of drug delivery such as drug concentration in target organs and drug pharmacokinetic activity in a patient’s body. Common drawbacks of conventional methods are the absence of precision, invasive procedures, significant time delay, and poor sensitivity [79].

Spatial resolution with conventional monitoring approaches, such as blood sampling and tissue biopsies, are the most limiting, as they do not provide insight into localized drug distribution or concentration gradients in target tissues. In many cases, invasive procedures such as tissue sampling or catheter placement are required to monitor these techniques. These strategies may result in patient discomfort, the risk of infection, and procedural risks. Furthermore, the timing of the feedback, including drug delivery kinetics, is poor with conventional monitoring approaches. Currently, feedback is frequently obtained long after administration. Therefore, adjusting treatment or optimizing therapeutic work regimens is challenging [80].

10. Future Outlook and Recommendations

With continued advancements in materials science, imaging technology, and biomedical engineering, biopolymer gels have a bright future ahead of them in theranostic applications. These advancements could help to realize the potential of biopolymer gels in biocompatibility and stability issues in general, improve imaging resolution and sensitivity, and address clinical interpretation and regulatory issues. Theranostic applications for nanoparticles coated with biopolymers have been investigated; however, further research is needed on long-term toxicity and safety. In addition to demonstrating the pilots for this work, scale-up technological exploration is required. Investigating the application of biopolymeric gel in conjunction with various nano formulations such as liposomes, micellar drug delivery, and dendrimers in detail is crucial. To demonstrate the theranostic utility of polymeric gels, further research is needed in the field of their integration with wearable sensors.

11. Conclusions

Biopolymer gels have become highly adaptable platforms for theranostic applications, combining imaging, real-time monitoring, and drug administration into cohesive systems for personalized and precision treatment. These gels, which can include imaging agents, are biocompatible, have customizable characteristics, and are made of natural or synthetic polymers that crosslink to form networks that resemble the extracellular matrix. Imaging agents are included into biopolymer gels to allow for real-time drug delivery tracking, precise therapeutic control, and treatment result optimization. The development of more advanced biopolymer gel systems with additional functionalities like stimuli responsiveness or self-healing qualities to further improve their therapeutic potential should be the main focus of future research efforts. These systems can be customized to particular biomedical applications.

References

Baranwal J, Barse B, Fais A, Delogu GL, Kumar A. Biopolymer: A sustainable material for food and medical applications. Polymers. 2022;14(5):983.
Mohan A, Santhamoorthy M, Phan TTV, Kim S-C. pNIPAm-Based pH and Thermoresponsive Copolymer Hydrogel for Hydrophobic and Hydrophilic Drug Delivery. Gels. 2024;10(3):184.
Fernandes SC, Aguirre G. Biopolymer micro/nanogel particles as smart drug delivery and theranostic systems. MDPI; 2023. p. 2060. [CrossRef]
Yuan W, Xu J, Yang N, Wang H, Li J, Zhang M, et al. Engineered Dynamic Hydrogel Niches for the Regulation of Redox Homeostasis in Osteoporosis and Degenerative Endocrine Diseases. Gels. 2023;10(1):31. [CrossRef]
Altuntaş E, Özkan B, Güngör S, Özsoy Y. Biopolymer-based nanogel approach in drug delivery: basic concept and current developments. Pharmaceutics. 2023;15(6):1644. [CrossRef]
Clark, A.H. Structural and mechanical properties of biopolymer gels. Food polymers, gels and colloids: Elsevier; 1991. p. 322-38.
Puccetti M, Pariano M, Schoubben A, Giovagnoli S, Ricci M. Biologics, theranostics, and personalized medicine in drug delivery systems. Pharmacological Research. 2024:107086. [CrossRef]
Zhao L, Kim T-H, Ahn J-C, Kim H-W, Kim SY. Highly efficient “theranostics” system based on surface-modified gold nanocarriers for imaging and photodynamic therapy of cancer. Journal of Materials Chemistry B. 2013;1(42):5806-17. [CrossRef]
Jeelani S, Reddy RJ, Maheswaran T, Asokan G, Dany A, Anand B. Theranostics: A treasured tailor for tomorrow. Journal of pharmacy and bioallied sciences. 2014;6(Suppl 1):S6-S8.
Lammers T, Aime S, Hennink WE, Storm G, Kiessling F. Theranostic nanomedicine. Accounts of chemical research. 2011;44(10):1029-38. [CrossRef]
Jaiswal T, Pisulkar SK, Kambala SS. Analysis of Antifungal and Antimicrobial Properties of Functionalized Denture Base Materials Using Chitosan Nanoparticles: A Systematic Review. Journal of Datta Meghe Institute of Medical Sciences University. 2021;16(4):801-5. [CrossRef]
Gonçalves C, Pereira P, Gama M. Self-assembled hydrogel nanoparticles for drug delivery applications. Materials. 2010;3(2):1420-60. [CrossRef]
Bhattacharya T, Preetam S, Ghosh B, Chakrabarti T, Chakrabarti P, Samal SK, et al. Advancement in biopolymer assisted cancer theranostics. ACS Applied Bio Materials. 2023;6(10):3959-83. [CrossRef]
Ayeldeen MK, Negm AM, El Sawwaf MA. Evaluating the physical characteristics of biopolymer/soil mixtures. Arabian Journal of Geosciences. 2016;9:1-13. [CrossRef]
Agrawal S, Budhwani D, Gurjar P, Telange D, Lambole V. Pullulan based derivatives: Synthesis, enhanced physicochemical properties, and applications. Drug delivery. 2022;29(1):3328-39.
Terreno E, Uggeri F, Aime S. Image guided therapy: the advent of theranostic agents. Journal of controlled release. 2012;161(2):328-37. [CrossRef]
Shrivastava S, Jain S, Kumar D, Soni SL, Sharma M. A review on theranostics: an approach to targeted diagnosis and therapy. Asian Journal of Pharmaceutical Research and Development. 2019;7(2):63-9. [CrossRef]
Gunde M, Telange D, Pimpale A, Pethe A. Quality by design driven development of topical gel encompassing papain and bromelain to elicit wound healing. Indian J Pharm Educ Res. 2023;57:s281-91. [CrossRef]
Burkett BJ, Bartlett DJ, McGarrah PW, Lewis AR, Johnson DR, Berberoğlu K, et al. A review of theranostics: perspectives on emerging approaches and clinical advancements. Radiology: Imaging Cancer. 2023;5(4):e220157. [CrossRef]
Thakare A, Sedani S, Kriplani S, Patel A, Umre U, Thakare Jr A, et al. Chitosan: A Versatile Biomaterial Revolutionizing Endodontic Therapy. Cureus. 2024;16(6). [CrossRef]
Islam MM, Shahruzzaman M, Biswas S, Sakib MN, Rashid TU. Chitosan based bioactive materials in tissue engineering applications-A review. Bioactive materials. 2020;5(1):164-83.
Lazaridou M, Bikiaris DN, Lamprou DA. 3D bioprinted chitosan-based hydrogel scaffolds in tissue engineering and localised drug delivery. Pharmaceutics. 2022;14(9):1978. [CrossRef]
Opriș O, Mormile C, Lung I, Stegarescu A, Soran M-L, Soran A. An overview of biopolymers for drug delivery applications. Applied Sciences. 2024;14(4):1383. [CrossRef]
Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy. Bioconjugate chemistry. 2011;22(10):1879-903.
Chavda VP, Balar PC, Nalla LV, Bezbaruah R, Gogoi NR, Gajula SNR, et al. Conjugated Nanoparticles for Solid Tumor Theranostics: Unraveling the Interplay of Known and Unknown Factors. ACS omega. 2023;8(41):37654-84.
Mahmood A, Patel D, Hickson B, DesRochers J, Hu X. Recent Progress in Biopolymer-Based Hydrogel Materials for Biomedical Applications. Int J Mol Sci. 2022;23(3). [CrossRef]
Panja S, Adams DJ. Stimuli responsive dynamic transformations in supramolecular gels. Chemical Society Reviews. 2021;50(8):5165-200.
Mercer IG, Italiano AN, Gazaryan IG, Steiner AB, Kazakov SV. Degradation Kinetics of Disulfide Cross-Linked Microgels: Real-Time Monitoring by Confocal Microscopy. Gels. 2023;9(10):782.
Melo BL, Lima-Sousa R, Alves CG, Moreira AF, Correia IJ, de Melo-Diogo D. Chitosan-based injectable in situ forming hydrogels containing dopamine-reduced graphene oxide and resveratrol for breast cancer chemo-photothermal therapy. Biochemical engineering journal. 2022;185:108529. [CrossRef]
Attama AA, Nnamani PO, Onokala OB, Ugwu AA, Onugwu AL. Nanogels as target drug delivery systems in cancer therapy: A review of the last decade. Frontiers in Pharmacology. 2022;13:874510. [CrossRef]
Laurent S, Mahmoudi M. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. International journal of molecular epidemiology and genetics. 2011;2(4):367. [CrossRef]
Dispinar T, Van Camp W, De Cock LJ, De Geest BG, Du Prez FE. Redox-responsive degradable PEG cryogels as potential cell scaffolds in tissue engineering. Macromolecular bioscience. 2012;12(3):383-94. [CrossRef]
He Y, Wang C, Wang C, Xiao Y, Lin W. An overview on collagen and gelatin-based cryogels: Fabrication, classification, properties and biomedical applications. Polymers. 2021;13(14):2299. [CrossRef]
Alshamrani, M. Broad-spectrum theranostics and biomedical application of functionalized nanomaterials. Polymers. 2022;14(6):1221.
Zhao L, Zhou Y, Zhang J, Liang H, Chen X, Tan H. Natural polymer-based hydrogels: From polymer to biomedical applications. Pharmaceutics. 2023;15(10):2514.
Mazuki N, Saadiah M, Fuzlin A, Khan N, Samsudin A. Basic aspects and properties of biopolymers. 2022. [CrossRef]
ALSamman MT, Sánchez J. Chitosan-and alginate-based hydrogels for the adsorption of anionic and cationic dyes from water. Polymers. 2022;14(8):1498. [CrossRef]
Lee EJ, Lee JH, Jin L, Jin OS, Shin YC, Oh SJ, et al. Hyaluronic acid/poly (lactic-co-glycolic acid) core/shell fiber meshes loaded with epigallocatechin-3-O-gallate as skin tissue engineering scaffolds. Journal of Nanoscience and Nanotechnology. 2014;14(11):8458-63. [CrossRef]
Huang H, Qi X, Chen Y, Wu Z. Thermo-sensitive hydrogels for delivering biotherapeutic molecules: A review. Saudi Pharmaceutical Journal. 2019;27(7):990-9. [CrossRef]
Deng H, Dong A, Song J, Chen X. Injectable thermosensitive hydrogel systems based on functional PEG/PCL block polymer for local drug delivery. Journal of Controlled Release. 2019;297:60-70. [CrossRef]
Alaswad SO, Mahmoud AS, Arunachalam P. Recent advances in biodegradable polymers and their biological applications: a brief review. Polymers. 2022;14(22):4924.
Hussain S, Mubeen I, Ullah N, Shah SSUD, Khan BA, Zahoor M, et al. Modern diagnostic imaging technique applications and risk factors in the medical field: A review. BioMed Research International. 2022;2022. [CrossRef]
Kasban H, El-Bendary M, Salama D. A comparative study of medical imaging techniques. International Journal of Information Science and Intelligent System. 2015;4(2):37-58.
Hsu JC, Nieves LM, Betzer O, Sadan T, Noël PB, Popovtzer R, et al. Nanoparticle contrast agents for X-ray imaging applications. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2020;12(6):e1642.
Methachan B, Thanapprapasr K. Polymer-based materials in cancer treatment: from therapeutic carrier and ultrasound contrast agent to theranostic applications. Ultrasound in medicine & biology. 2017;43(1):69-82.
Jeong Y, Hwang HS, Na K. Theranostics and contrast agents for magnetic resonance imaging. Biomaterials research. 2018;22(1):20.
Janib SM, Moses AS, MacKay JA. Imaging and drug delivery using theranostic nanoparticles. Advanced drug delivery reviews. 2010;62(11):1052-63.
Crișan G, Moldovean-Cioroianu NS, Timaru D-G, Andrieș G, Căinap C, Chiș V. Radiopharmaceuticals for PET and SPECT imaging: a literature review over the last decade. International journal of molecular sciences. 2022;23(9):5023.
Weissleder R, Schwaiger MC, Gambhir SS, Hricak H. Imaging approaches to optimize molecular therapies. Science translational medicine. 2016;8(355):355ps16-ps16.
Ou X, Chen X, Xu X, Xie L, Chen X, Hong Z, et al. Recent development in x-ray imaging technology: Future and challenges. Research. 2021.
Chan V, Perlas A. Basics of ultrasound imaging. Atlas of ultrasound-guided procedures in interventional pain management. 2011:13-9.
Van Geuns R-JM, Wielopolski PA, de Bruin HG, Rensing BJ, Van Ooijen PM, Hulshoff M, et al. Basic principles of magnetic resonance imaging. Progress in cardiovascular diseases. 1999;42(2):149-56.
Rao J, Dragulescu-Andrasi A, Yao H. Fluorescence imaging in vivo: recent advances. Current opinion in biotechnology. 2007;18(1):17-25.
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M. Nuclear imaging in cancer theranostics. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2007;51(2):152-63.
Gomes Marin JF, Nunes RF, Coutinho AM, Zaniboni EC, Costa LB, Barbosa FG, et al. Theranostics in nuclear medicine: emerging and re-emerging integrated imaging and therapies in the era of precision oncology. Radiographics. 2020;40(6):1715-40.
Ding H, Wu F. Image guided biodistribution and pharmacokinetic studies of theranostics. Theranostics. 2012;2(11):1040.
De La Vega JC, Häfeli UO. Utilization of nanoparticles as X-ray contrast agents for diagnostic imaging applications. Contrast media & molecular imaging. 2015;10(2):81-95.
Perera RH, Hernandez C, Zhou H, Kota P, Burke A, Exner AA. Ultrasound imaging beyond the vasculature with new generation contrast agents. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2015;7(4):593-608.
Arora S, Das G, Alqarni M, Grover V, Manzoor Baba S, Saluja P, et al. Role of chitosan hydrogels in clinical dentistry. Gels. 2023;9(9):698.
Nathanael AJ, Oh TH. Biopolymer coatings for biomedical applications. Polymers. 2020;12(12):3061.
Kučuk N, Primožič M, Knez Ž, Leitgeb M. Sustainable biodegradable biopolymer-based nanoparticles for healthcare applications. International journal of molecular sciences. 2023;24(4):3188.
Pei J, Yan Y, Palanisamy CP, Jayaraman S, Natarajan PM, Umapathy VR, et al. Materials-based drug delivery approaches: Recent advances and future perspectives. Green Processing and Synthesis. 2024;13(1):20230094.
Vashist A, Raymond AD, Chapagain P, Nair MP, Runowicz CD. Polyols and polyol-based hydrogels with anti-cancer activity. Google Patents; 2024.
Newman DK, Spero MA, Martins-Green M, Coates JD. Wound prevention and/or treatment and related compounds, matrices, compositions, methods and systems. Google Patents; 2021.
Loadman P, Falconer R, Gill J, Rao J, Daldrup-Link HE. Tumour-targeted theranostic. Google Patents; 2019.
Steinmetz, N.F. Polydopamine decorated tobacco mosaic theranostic virus nanoparticles. Google Patents; 2022.
Dravid VP, Sharma S, Tomita T, Viola KL, Klein WL. Magnetic nanostructures as theranostic agents. Google Patents; 2015.
Perez Figueroa JM, Santra S. Synthesis of hyperbranched amphiphylic polyester and theranostic nanoparticles thereof. 2013.
Kumar R, Sridhar S, Wilfred N, Cormack R, Makrigiorgos G. Biopolymer-nanoparticle composite implant for tumor cell tracking. Google Patents; 2020.
Wu XY, Shalviri A, Cai P. Polymeric nanoparticles useful in theranostics. Google Patents; 2019.
Körhegyi Z, Rózsa D, Hajdu I, Bodnár M, Kertesz I, Kerekes K, et al. Synthesis of 68Ga-labeled biopolymer-based nanoparticle imaging agents for positron-emission tomography. Anticancer research. 2019;39(5):2415-27.
Stanisz M, Klapiszewski Ł, Jesionowski T. Recent advances in the fabrication and application of biopolymer-based micro-and nanostructures: A comprehensive review. Chemical Engineering Journal. 2020;397:125409.
Jin M, Yu D-G, Geraldes CF, Williams GR, Bligh SA. Theranostic fibers for simultaneous imaging and drug delivery. Molecular pharmaceutics. 2016;13(7):2457-65.
Khobragade DS, Potbhare M, Patil A. Evaluation of gum sandarac as a novel release controlling coating polymer for formulation of sustained release pellets. Int J Adv Pharm. 2016;5:39-45.
Laffleur F, Keckeis V. Advances in drug delivery systems: Work in progress still needed? International journal of pharmaceutics. 2020;590:119912.
Madej-Kiełbik L, Gzyra-Jagieła K, Jóźwik-Pruska J, Dziuba R, Bednarowicz A. Biopolymer composites with sensors for environmental and medical applications. Materials. 2022;15(21):7493.
Chiu I, Yang T. Biopolymer-based intelligent packaging integrated with natural colourimetric sensors for food safety and sustainability. Analytical Science Advances. 2024:e202300065.
Abdullah, Cai J, Hafeez MA, Wang Q, Farooq S, Huang Q, et al. Biopolymer-based functional films for packaging applications: A review. Frontiers in Nutrition. 2022;9:1000116.
Ezike TC, Okpala US, Onoja UL, Nwike CP, Ezeako EC, Okpara OJ, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023;9(6).
Phutane P, Telange D, Agrawal S, Gunde M, Kotkar K, Pethe A. Biofunctionalization and applications of polymeric nanofibers in tissue engineering and regenerative medicine. Polymers. 2023;15(5):1202.

Figure 1. Theranostic applications of the biopolymer gel.

Figure 2. Properties of Biopolymer Gels.

Figure 3. Types of Imaging Agents.

Table 2. Patents filed on biopolymer gels for therapeutic and diagnostic applications.

S. No	Patent Number	Material used	Purpose	Remarks	Ref
1.	US11969438B1	vegetable oil-derived polyol.	Anti-cancer activity	Provides compositions and methods for selectively treating a cancer or tumor utilizing an effective amount of a vegetable oil-derived polyol or hydrogel particles comprising a vegetable oil-derived polyol. It provides a method of targeting and imaging various tumors and/or tumor associated macrophages	[63]
2.	US20210322462A1	Polyvinyl alcohol [PVA], Collagen-chitosan	Wound Prevention and/or Treatment	The composition in embedded in a hydrogel made of polyvinyl alcohol (PVA), collagen-chitosan, alginates, carbopol gels, alginate matrices for slow release	[64]
3.	US10201622B2	Gelatin, Casein, Dextran, PEG, PVP	Theranostic applications	Nanoparticles coated with polymers like Gelatin, Casein, Dextran, PEG, PVP addressed the theranostic applications.	[65]
4.	US11529430B2	Chitosan, polylactic acid, polyglycolic acid and copolymers	Contrast agent	Gadolinium DOTA nanoparticles decorated with polydopamine and as a photothermal agent to kill cancer cells	[66]
5.	US9095629B2	PEG and Nitro-DOPA	Magnetic nanoparticles	As contrast agent and Better targeting of the MNPs	[67]
6.	US8372944B1	Hyperbranched polyester and hyperbranched polyester amine	Polymeric nanoparticles as thenostic agent	Polymeric nanoparticles coated with HBPE for fluroscence and delivery of therapeutic drug	[68]
7.	US10799604B2	Polyethylene glycol, polyacrylic acid, polyacrylamide, poly[N-isopropylacrylamide], hyaluronic acid, and combinations thereof	Implant for tumor cell tracking	A method of treating cancer is provided by implanting one or more brachytherapy spacers or fiducial markers including the matrix material and an anti-cancer therapeutic agent dispersed within the matrix material.	[69]
8.	US20190233567A1	Polymethacrylic acid grafted starch	Therapeutics and/or signal molecules	The PMAA-g-St-DTPA-Gd nanoparticle shows promise for detecting pH deviations from the typical physiological pH of 7.4 in tumor tissue or infectious lesions through MR imaging. It has the ability to exhibit different levels of relaxivity at different pH values. To deliver therapeutic agents as the loaded cargo of nanoparticles for the treatment of any of the following: A neuropsychiatric disorder; a neurodegenerative disorder	[70]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.

MDPI Initiatives

Important Links

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

Disclaimer